Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)
Dermatol Ther (Heidelb). 2022 Dec 1. doi: 10.1007/s13555-022-00863-2. Online ahead of print.
NO ABSTRACT
PMID:36456890 | DOI:10.1007/s13555-022-00863-2
Von Automat